Identification of Prognostic Factors and New Therapeutic Targets in Cutaneous Lymphomas

Cutaneous T-cell lymphoma

Seattle Genetics, Inc. – Lymphoma, T-Cell, Cutaneous

A Phase I Trial of SIM1811-03 in Subjects With Advanced Tumors Characterization of the Microbiome in Cutaneous T Cell Lymphoma Skin Lesions Before and After Use of APR-TD011® (RLF-TD011®) Spray Solution A Phase I Trial of SIM1811-03 in Subjects With Advanced Solid Tumors and Cutaneous T-cell Lymphoma ATRA Plus G-CSF for Mobilization of Hematopoietic Stem and Progenitor Cells Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29 Identification of Prognostic Factors and New Therapeutic Targets in Cutaneous Lymphomas MORPHEE : Mechanisms of Cell Death Induced by Extracorporeal Photochemotherapy A PHASE 1, DOSE ESCALATION STUDY OF CDK-003 (exoIL-12) IN PATIENTS WITH CUTANEOUS T-CELL LYMPHOMA (CTCL) A Study of MEDI9197 in Subjects With Solid Tumors or CTCL and in Combination With Durvalumab and/or Palliative Radiation in Subjects With Solid Tumors